Get the Stockscreener App
4.315
1.17%
0.045
Annexon Inc stock is traded at $4.315, with a volume of 858.25K.
It is up +1.17% in the last 24 hours and up +38.02% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$4.27
Open:
$4.29
24h Volume:
858.25K
Relative Volume:
0.39
Market Cap:
$516.22M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-2.4379
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
+59.41%
1M Performance:
+38.02%
6M Performance:
+119.29%
1Y Performance:
-16.44%
1-Day Range:
$4.18
$4.415
1-Week Range:
$2.67
$5.07
52-Week Range:
$1.285
$5.66
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650) 822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
4.315 | 636.47M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.47 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
742.41 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.59 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
919.87 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
195.95 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Annexon: Maintaining "Buy" Rating On Second C1q Inhibitor Advancement For Geographic Atrophy - Seeking Alpha
Wells Fargo Boosts Annexon’s Price Target Amid Optimism for Trial Success - StocksToTrade
Annexon Shares Rise After Director's $5.06 Million Stock Purchase - MarketScreener
Annexon stock rises after director purchases shares - MSN
Annexon stock rises after director purchases shares (ANNX:NASDAQ) - Seeking Alpha
Annexon Stock Surges on Positive Vonaprument Phase 3 Outlook - timothysykes.com
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed By Investing.com - Investing.com Australia
Annexon, Inc. Stock (ANNX) Opinions on Recent Public Offering and Insider Purchase - Quiver Quantitative
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed - Investing.com
Why analysts upgrade Annexon Inc. stockQuarterly Portfolio Report & AI Enhanced Execution Alerts - newser.com
Annexon Insider Bought Shares Worth $5,055,000, According to a Recent SEC Filing - MarketScreener
Can Annexon Inc. stock beat analyst upgradesTreasury Yields & Smart Investment Allocation Insights - newser.com
Satter Muneer a buys Annexon (ANNX) shares worth $5m By Investing.com - Investing.com UK
Satter Muneer a buys Annexon (ANNX) shares worth $5m - Investing.com India
Is Annexon Inc. stock positioned for long term growth2025 Short Interest & Comprehensive Market Scan Insights - newser.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Annexon (ANNX) Rating Maintained, Price Target Raised by Wells Fargo | ANNX Stock News - GuruFocus
How sentiment analysis helps forecast Annexon Inc.2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Identifying reversal signals in Annexon Inc.Portfolio Update Summary & Proven Capital Preservation Methods - newser.com
Can Annexon Inc. stock deliver consistent earnings growth - newser.com
Key metrics from Annexon Inc.’s quarterly data2025 Performance Recap & Real-Time Volume Analysis - newser.com
Is Annexon Inc. stock a safe investment in uncertain marketsPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
Annexon Inc. recovery potential after sell offTrade Analysis Report & Proven Capital Preservation Methods - newser.com
Is Annexon Inc a good long term investmentDividend Stability Analysis & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Annexon Inc. stock momentum explainedWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Will Annexon Inc. stock deliver better than expected guidanceEarnings Overview Summary & Weekly Watchlist for Consistent Profits - newser.com
Annexon Biosciences (ANNX) Gets a Buy from Bank of America Securities - The Globe and Mail
Is Annexon Inc. stock a buy for dividend growthWeekly Stock Report & Fast Moving Stock Watchlists - newser.com
What drives Annexon Inc stock priceMarket Sentiment Report & Create Passive Income With Smart Stocks - earlytimes.in
Annexon Biosciences Completes Successful Public Offering - MSN
Can momentum traders help lift Annexon Inc.2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Annexon raises $86.25 million in public offering of common stock By Investing.com - Investing.com Canada
ANNX News Today | Why did Annexon stock go up today? - MarketBeat
Analyzing Annexon Inc. with multi timeframe charts2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Can Annexon Inc. stock surprise with earnings upsideQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
Annexon raises $86.25 million in public offering of common stock - Investing.com
Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million - The Manila Times
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):